钆基对比剂过敏样超敏反应:154539例患者8年队列研究
该回顾性队列研究分析了2012年7月1日至2020年6月30日首尔国立大学医院331070例钆基对比剂暴露中1304例超敏反应(0.4%),其中急性1178例(0.4%)、迟发126例(0.04%)。有急性超敏反应史者预防用药(OR=0.7,P=0.041)和更换钆基对比剂类型(OR=0.2,P<0.001)均有预防效果;有迟发反应史者仅预防用药(OR=0.2,P=0.016)显著降低超敏反应发生率。有碘对比剂超敏反应史者发生钆基对比剂超敏反应风险更高(OR=4.6,P<0.001)。
要点
- 钆基对比剂超敏反应总发生率为0.4%,其中急性0.4%、迟发0.04%。
- 有急性超敏反应史者,预防用药(OR=0.7,P=0.041)和更换钆基对比剂类型(OR=0.2,P<0.001)均有预防效果。
- 有迟发反应史者仅预防用药(OR=0.2,P=0.016)显著降低超敏反应发生率。
核心结论
- 钆基对比剂超敏反应发生率为0.4%;未预防用药、重复暴露于致敏钆基对比剂以及有碘对比剂和钆基对比剂超敏反应史是钆基对比剂超敏反应的危险因素。
研究设计与样本
- 回顾性分析2012年7月1日至2020年6月30日首尔国立大学医院所有对比剂超敏反应病例,共331070例钆基对比剂暴露、154539例患者,收集年龄、性别、钆基对比剂类型、发生时间和严重程度等信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background With the widespread use of gadolinium-based contrast agents (GBCAs), the incidence of allergic-like hypersensitivity reactions (HSRs) to GBCAs is increasing. Research on the incidence and risk factors for HSRs to GBCAs is needed for their safe use. Purpose To determine the incidence of acute and delayed reactions to GBCAs and to discuss the risk factors and strategies for the prevention of HSRs to GBCAs. Materials and Methods All cases of HSRs to contrast media that occurred at the Seoul National University Hospital from July 1, 2012, to June 30, 2020, were assessed. Information including age, sex, GBCA type, onset, and severity of HSRs was retrospectively analyzed. Results Among the 331070 cases of GBCA exposure in 154539 patients, 1304 cases of HSRs (0.4%) were reported. Acute HSRs accounted for 1178 cases (0.4%), while 126 cases (0.04%) were delayed HSRs. While both premedication (odds ratio [OR] = 0.7, P = .041) and changing the type of GBCA (OR = 0.2, P < .001) showed preventative effects in patients with a history of acute HSRs, only premedication (OR = 0.2, P = .016) significantly reduced the incidence of HSRs in patients with a history of delayed reactions. The risk of an HSR to GBCA was higher in those with a history of an HSR to iodinated contrast media (OR = 4.6, P < .001). Conclusion The rate of hypersensitivity reactions (HSRs) to gadolinium-based contrast agents (GBCAs) was 0.4%. The absence of premedication, repeated exposures to the culprit GBCA, and a history of HSRs to iodinated contrast media and GBCAs were risk factors for HSRs to GBCAs. © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Kallmes and McDonald in this issue.
引用
- Ahn, Kang, Park, et al. Allergic-like Hypersensitivity Reactions to Gadolinium-based Contrast Agents: An 8-year Cohort Study of 154 539 Patients. Radiology. 2022. PMID: 35191737. doi:10.1148/radiol.210545
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。